首页> 外文OA文献 >Issues around the prescription of half tablets in northern Switzerland: the irrational case of quetiapine
【2h】

Issues around the prescription of half tablets in northern Switzerland: the irrational case of quetiapine

机译:关于瑞士北部半片药处方的问题:喹硫平的不合理情况

摘要

Background. Prescription of fragmented tablets is useful for individualisation of dose but includes several drawbacks. Although without score lines, the antipsychotic drug quetiapine was in 2011 the most often prescribed 1/2 tablet in discharge prescriptions at the University Hospital in Basel (USB, 671 beds). We aimed at analysing the prescription patterns of split tablets in general and of quetiapine in particular in Switzerland. Methods. All orders of community pharmacies for unit-of-use soft pouch blisters placed at Medifilm AG, the leader company in Switzerland for repackaging into pouch blisters, were analysed. Results. Out of 4,784,999 tablets that were repacked in 2012 in unit-of-use pouch blisters, 8.5% were fragmented, mostly in half (87.6%), and were predominantly psycholeptics (pipamperone 15.8%). Prescription of half quetiapine appears to be a Basel specificity (highest rates of fragments and half quetiapine). Conclusions. Prescription of fragmented tablet is frequent. It represents a safety issue for the patient, and a pharmaceutical care issue for the pharmacist. In ambulatory care, the patient's cognitive and physical capacities must be clarified, suitability of the splitting of the tablet must be checked, appropriate aids must be offered, like a pill-splitting device in order to improve accuracy, and safe use of the drug must be ensured.
机译:背景。片剂碎片的处方可用于剂量的个体化,但有一些缺点。尽管没有评分标准,但抗精神病药物喹硫平在巴塞尔大学医院(USB,有671张病床)中是出院处方中最常用的1/2片。我们旨在分析一般拆分片剂的处方模式,尤其是瑞士的喹硫平的处方模式。方法。分析了放在瑞士领先企业Medifilm AG上的用于重新包装成袋装水泡的单位使用软袋装水泡的社区药房的所有订单。结果。在2012年以单位使用的水泡包装的4,784,999片药片中,有8.5%的成分呈碎片状,大部分为一半(87.6%),主要是精神病药物(pipamperone为15.8%)。半喹硫平的处方似乎是一种巴塞尔特异性(片段和半喹硫平的最高发生率)。结论。片剂碎片的处方很常见。对于患者而言,这代表安全问题,对于药剂师而言,则代表药物保健问题。在非卧床护理中,必须弄清楚患者的认知和身体能力,必须检查片剂的分裂适用性,并且必须提供适当的辅助手段,例如药丸分裂装置,以提高准确性,并且必须安全使用药物得到保证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号